<DOC>
	<DOCNO>NCT00896766</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample bone marrow blood patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study look lymphoblast young patient high-risk acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Laboratory Study Lymphoblasts Young Patients With High-Risk Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Identify region copy number abnormality ( CNA ) uniparental disomy leukemic lymphoblast pediatric patient high-risk acute lymphoblastic leukemia ( ALL ) use Affymetrix GeneChip Mapping 500K array set . ( Pilot project ) - Identify region CNA loss-of-heterozygosity use Affymetrix SNP 6.0 microarrays . ( Expansion project ) - Define gene expression profile leukemic lymphoblast use Affymetrix U133 Plus 2.0 array . - Assess global expression microRNAs leukemic lymphoblast use microRNA gene chip . - Utilize array-generated gene expression data data CNAs uniparental disomy prioritize candidate gene genomic region resequencing . - Characterize epigenomic profile use HpaII tiny fragment Enrichment Ligation-mediated PCR ( HELP ) assay . ( Expansion project ) - Discover candidate therapeutic target patient identify gene consistently mutate leukemic lymphoblast use high-throughput focus gene resequencing . ( Pilot project ) - Discover candidate therapeutic target patient next generation sequence technology , include whole genome , whole transcriptome , whole exome . ( Expansion project ) OUTLINE : This multicenter study . Banked biological sample ( bone marrow peripheral blood ) analyze use gene expression profiling , single-nucleotide polymorphism genotyping assay , DNA copy number loss heterozygosity estimate , epigenetic profiling , gene resequencing . PROJECTED ACCRUAL : A total 150 patient sample accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis Bcell precursor acute lymphoblastic leukemia ( ALL ) Highrisk disease Participation clinical trial COGP9906 require ( pilot project ) In complete remission Consented future study use banked tissue specimens Participation clinical trial COGAALL03B1 link therapeutic study COGAALL0232 COG AALL0331 ( expansion project ) Experienced bone marrow relapse within 36 month initial diagnosis Consented future study use banked tissue specimen Have match ALL blast germline specimens Demographic , clinical pathologic data element biospecimens available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
</DOC>